Key Takeaway: Telix has announced a significant milestone with 28 company-related abstract presentations scheduled for the 38th Annual Congress of the European Association of Nuclear Medicine (EANM) in Barcelona. This record-breaking presence highlights the company's growing influence in the nuclear medicine sector. The conference will take place from October 4 to 8, 2025.
Price reaction · baseline $9.57 (2025-09-30 close) · hit pre-market · 1 other TLX headline(s) in the window, move may be shared
day 0 close
+6.3%
day 1 · peak
+6.8%
day 3
+6.4%
Market Sentiment Analysis
POSITIVE FACTORS
Record-breaking conference presence with 28 presentations.
Participation at a prestigious event like EANM.
Increased visibility for Telix in the nuclear medicine field.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+13%
120-day peak, hindsight
Typical move
7%
average across 7 past catalysts
Lead asset
131I-IPA
Phase 1 · Neoplastic Disease
Full Press Release Details
Melbourne (Australia) and Indianapolis, IN (U.S) | 23 September 2025
Telix today announces its record-breaking conference presence with 28 company-related abstract presentations at the 38 th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in Barcelona from 4 – 8 October 2025.
Frequently Asked Questions
What is the significance of Telix's presence at EANM 2025?
Telix's record-breaking presence with 28 presentations highlights its advancements in nuclear medicine.
When will the EANM 2025 conference take place?
The EANM 2025 conference will be held from October 4 to 8, 2025.
Where is the EANM 2025 conference located?
The EANM 2025 conference will take place in Barcelona, Spain.
How many presentations will Telix have at EANM 2025?
Telix will have a record 28 company-related abstract presentations at EANM 2025.